Solymbic Euroopan unioni - bulgaria - EMA (European Medicines Agency)

solymbic

amgen europe b.v. - адалимумаб - arthritis, psoriatic; spondylitis, ankylosing; crohn disease; colitis, ulcerative; hidradenitis suppurativa; psoriasis; arthritis, rheumatoid - Имуносупресори - Моля, направете справка в раздел 4. 1 от Кратката характеристика на продукта в документа с информация за продукта.

Cyltezo Euroopan unioni - bulgaria - EMA (European Medicines Agency)

cyltezo

boehringer ingelheim international gmbh - адалимумаб - hidradenitis suppurativa; arthritis, psoriatic; psoriasis; crohn disease; arthritis, juvenile rheumatoid; uveitis; arthritis, rheumatoid; colitis, ulcerative; spondylitis, ankylosing - Имуносупресори - Моля, направете справка в раздел 4. 1 от Кратката характеристика на продукта в документа с информация за продукта.

AQUADOX BG 500 mg/g Bulgaria - bulgaria - БАБХ (Българска агенция по безопасност на храните)

aquadox bg 500 mg/g

Фарма СИС БГ ООД - Доксициклин гиклат - прах за прилагане във вода за пиене/мляко - 500 mg/g - пилета, прасета, телета

DOXYVET 500 WSP 500 mg/g Bulgaria - bulgaria - БАБХ (Българска агенция по безопасност на храните)

doxyvet 500 wsp 500 mg/g

kepro b.v. - Доксициклин гиклат - прах за перорален разтвор - 500 mg/g - пилета, прасета, телета

Doxyveto-C 500 mg/g прах за прилагане във вода за пиене/млекозаметител за говеда, свине, пилета 500 mg/g Bulgaria - bulgaria - БАБХ (Българска агенция по безопасност на храните)

doxyveto-c 500 mg/g прах за прилагане във вода за пиене/млекозаметител за говеда, свине, пилета 500 mg/g

v.m.d.n.v. - доксициклин гиклат - прах за прилагане във вода за пиене/млекозаместител - 500 mg/g - бройлери, говеда, кокошки, прасета, телета

DOXYMAX 50 % WSP 50 g/100 g Bulgaria - bulgaria - БАБХ (Българска агенция по безопасност на храните)

doxymax 50 % wsp 50 g/100 g

tolnagro ÁllatgyÓgyÁszati kft - Доксициклин гиклат - перорален прах - 50 g/100 g - птици, свине

HYDRODOXX-P 10% water soluble premix Bulgaria - bulgaria - БАБХ (Българска агенция по безопасност на храните)

hydrodoxx-p 10% water soluble premix

Биовет АД - Доксициклин (доксициклина гиклат а); аскорбинова киселина - медикаментозен премикс - 100 mg/g; 80 mg/g - бройлери, пуйки, свине

TETRAVET 50% PREMIX 500g/1000g Bulgaria - bulgaria - БАБХ (Българска агенция по безопасност на храните)

tetravet 50% premix 500g/1000g

seva sante animale - Окситетрациклин дигидрат - медикаментозен премикс - 500g/1000g - пуйки

Zolsketil pegylated liposomal Euroopan unioni - bulgaria - EMA (European Medicines Agency)

zolsketil pegylated liposomal

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Celdoxome pegylated liposomal Euroopan unioni - bulgaria - EMA (European Medicines Agency)

celdoxome pegylated liposomal

yes pharmaceutical development services gmbh - доксорубицин хидрохлорид - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - Антинеопластични средства - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).